The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce 11 new member-led technology, workforce development, and Global Health Fund projects with a value of ~$11.2 million through the Institute’s Project Call 8.1. This new slate of collaborative projects addresses key industry challenges and aims...
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) announces the selection of 100 first- and second-year college students to participate in the 2025 NIIMBL experience program. Students were selected from 75 academic institutions across the United States and Puerto Rico to take part in one of seven NIIMBL eXperience...
Today, Commissioners from the National Security Commission on Emerging Biotechnology (NSCEB), along with Senator Chris Coons (D-DE) and Representative Sarah McBride (D-DE), visited the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to see firsthand how government and industry partnerships drive excellence in...
Ten years ago today, Congress enacted the Revitalizing American Manufacturing and Innovation Act , establishing Manufacturing USA.
We are especially grateful for the people in the advanced manufacturing network and the countless milestones and achievements since the program’s inception, particularly this past year.
In honor of our 10 th...
Advanced manufacturing impacts our everyday lives, economic competitiveness, national security, and sustainability making it a vital component of the American economy. In the past decade, the American manufacturing landscape has transformed, and the Manufacturing USA network is leading the call to ensure that what is invented here stays here and...
